NSIS B — Novozymes A/S Cashflow Statement
0.000.00%
Last trade - 00:00- DKK190.85bn
- DKK212.92bn
- €3.83bn
- 80
- 15
- 72
- 57
Annual cashflow statement for Novozymes A/S, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | Final |
| Net Income/Starting Line | 379 | 423 | 496 | 408 | 306 |
| Depreciation | |||||
| Non-Cash Items | 128 | 105 | 60.5 | 103 | 197 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -92.7 | -172 | -217 | -140 | -80.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 584 | 546 | 539 | 557 | 1,020 |
| Capital Expenditures | -126 | -167 | -389 | -276 | -360 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -78.4 | -203 | 29.3 | -10.3 | 160 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale of Intangible Assets | |||||
| Cash from Investing Activities | -204 | -369 | -359 | -286 | -200 |
| Financing Cash Flow Items | -39.4 | -0.134 | -0.134 | -4.16 | -86 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -310 | -213 | -168 | -254 | -703 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 63.1 | -29.3 | 10.5 | 10.1 | 130 |